abrdn Life Sciences Investors HQL:NYSE

RT Quote | Last NYSE, VOL From CTA | USD
Last | 05/03/24 EDT
13.59quote price arrow up+0.11 (+0.82%)
Volume
54,007
52 week range
11.34 - 14.37
Loading...
  • Open13.60
  • Day High13.72
  • Day Low13.56
  • Prev Close13.48
  • 52 Week High14.37
  • 52 Week High Date01/12/24
  • 52 Week Low11.34
  • 52 Week Low Date10/27/23

Key Stats

  • Market Cap371.694M
  • Shares Out27.35M
  • 10 Day Average Volume0.09M
  • Dividend1.33
  • Dividend Yield9.79%
  • Beta0.72
  • YTD % Change0.97

KEY STATS

  • Open13.60
  • Day High13.72
  • Day Low13.56
  • Prev Close13.48
  • 52 Week High14.37
  • 52 Week High Date01/12/24
  • 52 Week Low11.34
  • 52 Week Low Date10/27/23
  • Market Cap371.694M
  • Shares Out27.35M
  • 10 Day Average Volume0.09M
  • Dividend1.33
  • Dividend Yield9.79%
  • Beta0.72
  • YTD % Change0.97

RATIOS/PROFITABILITY

  • EPS (TTM)0.87
  • P/E (TTM)15.60
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-2.175M
  • ROE (TTM)5.59%
  • Revenue (TTM)3.499M
  • Gross Margin (TTM)-35.89%
  • Net Margin (TTM)638.85%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date02/21/2024
  • Div Amount0.39
  • Split Date-
  • Split Factor-

Latest On abrdn Life Sciences Investors

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
abrdn Life Sciences Investors (the Fund), formerly Tekla Life Sciences Investors, is a non-diversified closed-end management investment company. The Fund's investment objective is long-term capital appreciation through investment in United States and foreign companies in the life sciences industry, including biotechnology, pharmaceutical, diagnostics, managed healthcare and medical equipment, hospitals, healthcare information technology and services, devices and supplies, and...
Daniel Omstead Ph.D.
President, Trustee
Address
1900 Market Street, Suite 200
Philadelphia, PA
19103
United States